Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beximco Faces Potentially Rough Ride In The Face Of Macroeconomic Headwinds

Revenue Grows But Profits Take A Hit At Bangladeshi Generics Firm

Executive Summary

Following a year of impressive business developments, economic developments such as a depreciating local currency threaten to knock Beximco off-course.

You may also be interested in...



Beximco Grows With 20 Launches In Financial First Half

Bangladesh-based Beximco has delivered double-digit growth in its financial first half ended 31 December 2021, on the back of 20 new product launches domestically and expanding into new markets internationally. 

Beximco Completes Acquisition Of Sanofi Bangladesh

Beximco has completed its acquisition of a majority stake in Sanofi Bangladesh to “expand its core capabilities and product offerings.” With its second major acquisition under its belt, Beximco said that it plans to continue its diversification and expansion.

Nichi-Iko Set To Delist In March As Tamura Steps Down As CEO

After nearly two difficult years for Nichi-Iko Pharmaceutical, the firm has announced at it will be acquired by a private equity fund and delisted from the Toyko Stock Exchange in 2023 and its CEO will step down from his post.

Topics

Latest News
See All
UsernamePublicRestriction

Register

GB152305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel